Tenosynovial giant cell tumor

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

1FDA treatments

10Recruiting trials

Regulatory Watchboard

10 events

Apr 2026Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany — PHASE2

TrialNOT YET RECRUITING

Apr 2026Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis

Nantes University Hospital — NA

TrialNOT YET RECRUITING

Jan 2026Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor Surgery

Shanghai Jiao Tong University Affiliated Sixth People's Hospital — PHASE4

TrialRECRUITING

Sep 2025Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib

Deciphera Pharmaceuticals, LLC

TrialRECRUITING

Dec 2024A Comparative Study of the Efficacy of Multimodal Interventions for Tenosynovitis

Zixin Deng — NA

TrialNOT YET RECRUITING

Oct 2024Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)

SynOx Therapeutics Limited — PHASE3

TrialACTIVE NOT RECRUITING

Apr 2023Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)

Abbisko Therapeutics Co, Ltd — PHASE3

TrialACTIVE NOT RECRUITING

Oct 2021Study of Vimseltinib for Tenosynovial Giant Cell Tumor

Deciphera Pharmaceuticals, LLC — PHASE3

TrialACTIVE NOT RECRUITING

Mar 2021A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

Daiichi Sankyo Co., Ltd. — PHASE2

TrialACTIVE NOT RECRUITING

Jan 2021A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

Daiichi Sankyo

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

TURALIO

Daiichi Sankyo, Inc.

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

TURALIO

(pexidartinib)Orphan drug

Daiichi Sankyo, Inc.

12.1 Mechanism of Action Pexidartinib is a small molecule tyrosine kinase inhibitor that targets colony stimulating factor 1 receptor (CSF1R), KIT pro...

Approved Aug 2019FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

10 active trials

4Phase 3

1Phase 4

1Phase 2

1Phase 1

2Unknown

1PHASE1, PHASE2

10Total recruiting

Search clinical trials for Tenosynovial giant cell tumor →

Recent News & Research

No recent news articles indexed yet for Tenosynovial giant cell tumor.
Search PubMed for Tenosynovial giant cell tumor →

Browse all Tenosynovial giant cell tumor news →

Specialist Network

Top 6 by expertise

Global Clinical Leader

Daiichi Sankyo

Score 3644 trials4 pubs

Jean Y Blay, Prof, MD

Comprehensive Cancer Centre of Lyon

Score 111 trial

Jessica Gartrell, MD, MD

St. Jude Children's Research Hospital

📍 MEMPHIS, TN

Score 92 trials

Rosandra N Kaplan, M.D.

National Cancer Institute (NCI)

📍 Bethesda, Maryland

Score 94 trials

Global Team Leader

Daiichi Sankyo

Score 66 trials

Maitreyi Sharma, MD, M.D

Deciphera Pharmaceuticals, LLC

📍 BOSTON, MA

View all Tenosynovial giant cell tumor specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles